Adlai Nortye ANL
NASDAQ ANL
$15.65 +0.25 (+1.62%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Operating Leases (2022 - 2026)

Updated

Adlai Nortye (ANL) reported Operating Leases of $772,000 for Q2 2026, up 200.4% from $257,000 a year earlier.

Analysis

Adlai Nortye (ANL) Operating Leases (2022 - 2026) Analysis & Trends

At the end of FY2025, Adlai Nortye posted Operating Leases of $667,000, up 41.6% from FY2024.

  • Operating Leases has a three-year compound annual growth rate of -18.6% (FY2022 to FY2025).
  • By year, Operating Leases came in at $471,000 in FY2024 (+0.4%), $469,000 in FY2023 (-62.1%) and $1.24 million in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly Operating Leases since Q4 2022.
  • Year over year, Operating Leases gained in three of the last four quarters, with growth averaging 45.7%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Adlai Nortye 528.79 Mn 429.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 772,000.00
Dec 31, 2025 667,000.00
Jun 30, 2025 257,000.00
Dec 31, 2024 471,000.00
Jun 30, 2024 637,000.00
Dec 31, 2023 469,000.00
Dec 31, 2022 1.24 Mn
API Access

Adlai Nortye Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ANL&period=max&api_key=YOUR_API_KEY